S1b3inL1

Description: S1b3inL1 is a macrocylcic peptide inhibitor of the SARS-CoV-2 spike protein. It binds with high affinity to a conserved site on the spike protein, effectively suppressing the infection of various SARS-CoV-2 variants. S1b3inL1 exhibits antiviral activity. Target: SARS-CoV. Smiles: C(C=1C=2C(NC1)=CC=CC2)[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@]([C@H](CC)C)(NC(=O)[C@]([C@H](CC)C)(NC(=O)[C@]([C@H](CC)C)(NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@]4(N(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC5=CC=C(O)C=C5)NC(=O)CSC[C@@H](C(NCC(N)=O)=O)NC(=O)[C@H](CC6=CC=CC=C6)NC(=O)[C@H]([C@H](C)C)NC3=O)CCC4)[H])[H])[H])[H]